- Presentations
- 2
- Markets
- 1
Tevimbra is a brand of Tislelizumab marketed by BeOne Medicines, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tislelizumab
- Brand owner
- BeOne Medicines
- Registered in
- United States
- Strengths and forms
- 100 mg/10 mL injection, 150 mg/15 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tevimbra 100 mg/10 mL injectionIntravenous Cold chain | BeOne Medicines | US FDA | Available on request |
| Tevimbra 150 mg/15 mL injectionIntravenous Cold chain | BeOne Medicines | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tevimbra
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.